Published in Nat Clin Pract Endocrinol Metab on July 08, 2008
Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med (2008) 4.98
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int (2008) 3.34
Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin. J Am Soc Nephrol (2008) 2.72
Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol (2007) 2.62
Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis (2008) 2.31
A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol (2003) 2.23
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation (2011) 1.87
Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis (2009) 1.79
Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis (2009) 1.74
A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment. Kidney Int (2009) 1.72
Pure red cell aplasia due to follow-on epoetin. Kidney Int (2008) 1.69
Fournier gangrene: role of imaging. Radiographics (2008) 1.68
Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization. Am J Kidney Dis (2009) 1.66
Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation. Kidney Int (2008) 1.43
Alcohol and sexual risk behavior among migrant female sex workers and male workers in districts with high in-migration from four high HIV prevalence states in India. AIDS Behav (2010) 1.43
Acute coronary syndrome in ESRD patients. Kidney Int (2008) 1.43
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis (2012) 1.38
Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route. Infect Immun (2007) 1.37
Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease. Kidney Int (2008) 1.34
Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology (2013) 1.34
Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant (2009) 1.33
Disclosure of the HIV infection status in children. Indian J Pediatr (2009) 1.27
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. Am Heart J (2005) 1.25
Aerosol chemistry over a high altitude station at northeastern Himalayas, India. PLoS One (2010) 1.19
Does TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol (2009) 1.17
Con: Randomized controlled trials (RCT) have failed in the study of dialysis methods. Nephrol Dial Transplant (2013) 1.09
Polymer thin films embedded with metal nanoparticles for electrochemical biosensors applications. Biosens Bioelectron (2012) 1.06
Prevalence of vitamin D deficiency in Saudi adults. Saudi Med J (2013) 1.02
The role of systemic handling in the pathophysiologic actions of botulinum toxin. J Pharmacol Exp Ther (2008) 1.01
Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination. Infect Immun (2002) 1.00
Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - a pilot study. Saudi J Kidney Dis Transpl (2010) 0.96
New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J Kidney Dis (2004) 0.95
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis (2009) 0.95
Strategies for preservation of ovarian and testicular function after immunosuppression. Am J Kidney Dis (2004) 0.92
Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database. Transplantation (2006) 0.92
Skull metastasis in papillary carcinoma of thyroid: A case report. World J Radiol (2012) 0.90
Role of vitamin D in chronic kidney disease. Semin Nephrol (2009) 0.90
Outcome of acute kidney injury in pediatric patients admitted to the intensive care unit. Clin Nephrol (2014) 0.89
Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease. Am J Nephrol (2013) 0.88
Chronic kidney disease in the Arab world: a call for action. Nephron Clin Pract (2012) 0.88
Endothelial activation markers in anemic non-dialysis chronic kidney disease patients. Nephron Clin Pract (2008) 0.87
Tc-99m ciprofloxacin scans for detection of tubercular bone infection. Clin Nucl Med (2007) 0.87
Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure. Clin J Am Soc Nephrol (2006) 0.87
ESAs in dialysis patients: are you a hedgehog or a fox? J Am Soc Nephrol (2010) 0.86
Nephrobronchial fistula complicating neglected nephrolithiasis and xanthogranulomatous pyelonephritis. Saudi J Kidney Dis Transpl (2011) 0.85
De novo multifocal renal cell carcinoma in the renal allograft. Kidney Int (2008) 0.84
Transformation of tomato with a bacterial codA gene enhances tolerance to salt and water stresses. J Plant Physiol (2011) 0.83
Posttransplant anemia: the role of sirolimus. Kidney Int (2009) 0.83
Rapidly deteriorating kidney function in a young man previously diagnosed with membranous nephropathy. Nephron Clin Pract (2010) 0.82
Anemia in chronic kidney disease: new advances. Heart Fail Clin (2010) 0.82
The role of kidney biopsy in the management of lupus nephritis. Curr Opin Nephrol Hypertens (2005) 0.81
Acute phosphate nephropathy. Kidney Int (2008) 0.81
Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. Am J Kidney Dis (2012) 0.81
Immunopathogenesis of lupus and lupus nephritis: recent insights. Curr Opin Nephrol Hypertens (2002) 0.81
The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis. Clin J Am Soc Nephrol (2010) 0.80
Anemia of chronic kidney disease. Clin J Am Soc Nephrol (2007) 0.79
Imaging of inflammatory bowel disease: CT and MR. Dig Dis (2004) 0.79
Comprehensive laboratory evaluation of a specific lateral flow assay for the presumptive identification of abrin in suspicious white powders and environmental samples. Biosecur Bioterror (2014) 0.79
Deciphering the binding modes of hematoporphyrin to bovine serum albumin. Indian J Biochem Biophys (2014) 0.79
Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions. Semin Nephrol (2009) 0.79
Brain lesions with elevated lactic acid peaks on magnetic resonance spectroscopy. Curr Probl Diagn Radiol (2004) 0.78
The optimal hemoglobin in dialysis patients- a critical review. Semin Dial (2008) 0.78
A new method for radiolabeling of human immunoglobulin-G and its biological evaluation. J Pharm Bioallied Sci (2012) 0.78
Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol (2008) 0.78
Complications of chronic kidney disease: anemia, mineral metabolism, and cardiovascular disease. Med Clin North Am (2005) 0.78
An electrochemiluminescence assay for the detection of bio threat agents in selected food matrices and in the screening of Clostridium botulinum outbreak strains associated with type A botulism. J Sci Food Agric (2013) 0.78
How ions affect the structure of water: a combined Raman spectroscopy and multivariate curve resolution study. J Phys Chem B (2013) 0.78
Anaemia of CKD--the CHOIR study revisited. Nephrol Dial Transplant (2007) 0.78
Hemoglobin target in chronic kidney disease: a pediatric perspective. Pediatr Nephrol (2008) 0.77
Therapy with erythropoiesis-stimulating agents and renal and nonrenal outcomes. Heart Fail Clin (2010) 0.77
Ultrafast intermolecular hydrogen bond dynamics in the excited state of fluorenone. J Phys Chem A (2005) 0.77
Iron deficiency in non-dialysis chronic kidney disease. Kidney Int (2008) 0.77
Reducing versus discontinuing erythropoietin at high hemoglobin levels. J Am Soc Nephrol (2007) 0.77
Efficacy of indigenously developed single vial kit preparation of 99mTc-ciprofloxacin in the detection of bacterial infection: an Indian experience. Nucl Med Commun (2008) 0.76
Modulation of platelet activation in chronic kidney disease patients on erythropoiesis-stimulating agents. Clin Appl Thromb Hemost (2012) 0.76
Is it time to reconsider subcutaneous administration of epoetin? Nephrol News Issues (2007) 0.76
ACP Journal Club. 24-hour isotonic sodium choloride was better than 7-hour sodium bicarbonate for preventing CIN. Ann Intern Med (2012) 0.75
Anaemia: Does the KDIGO guideline move the needle in CKD anaemia? Nat Rev Nephrol (2012) 0.75
Plastid transformation in eggplant. Methods Mol Biol (2014) 0.75
A comparative study of antioxidant potential of low density lipoprotein in type 2 diabetic men and women. Indian J Endocrinol Metab (2012) 0.75
Diagnosis of mandibular osteomyelitis in probable coexisting tumor recurrence: role of Tc-99m ciprofloxacin imaging. Clin Nucl Med (2008) 0.75
Predictors of renal replacement therapy and mortality in children with chronic kidney disease. Saudi Med J (2015) 0.75
Effect of dust and anthropogenic aerosols on columnar aerosol optical properties over Darjeeling (2200 m asl), eastern Himalayas, India. PLoS One (2012) 0.75
Water in the hydration shell of halide ions has significantly reduced Fermi resonance and moderately enhanced Raman cross section in the OH stretch regions. J Phys Chem B (2013) 0.75
Nontraumatic emergencies of abdominal aorta. Semin Ultrasound CT MR (2008) 0.75
Low energy, low latency and high speed array divider circuit using a shannon theorem based adder cell. Recent Pat Nanotechnol (2009) 0.75
The role of hydrogen-bonding interactions in the ultrafast relaxation dynamics of the excited states of 3- and 4-aminofluoren-9-ones. Chemphyschem (2009) 0.75
Prevention of intravenous contrast-induced nephropathy in hospital inpatients. Crit Pathw Cardiol (2008) 0.75
The nephrology quiz and questionnaire: 2006. Clin J Am Soc Nephrol (2007) 0.75
Antiglomerular basement membrane disease associated with Castleman disease. Am J Med Sci (2009) 0.75
Review: In diabetes, intensive and standard glycemic control do not differ for end-stage kidney disease or death. Ann Intern Med (2017) 0.75
The etiology of anemia in heart failure. Preface. Heart Fail Clin (2010) 0.75
A potential living kidney donor with prediabetes. Kidney Int (2009) 0.75
Inflammatory fatty masses of the abdomen. Semin Ultrasound CT MR (2008) 0.75
Uncertainty in the treatment of anemia in chronic kidney disease. Rev Cardiovasc Med (2005) 0.75
Islands of CdSe nanoparticles within Se nanofibers: a room temperature ionic liquid templated synthesis. Dalton Trans (2013) 0.75
Message to the FDA on ESAs: REMS is not enough, more studies are needed. Clin J Am Soc Nephrol (2010) 0.75
Generation of counter ion radical (Br2(•-)) and its reactions in water-in-oil (CTAB or CPB)/n-butanol/cyclohexane/water) microemulsion. J Phys Chem B (2011) 0.75
Hemoglobin maintenance with use of extended dosing of epoetin alfa in patients with diabetes and anemia of chronic kidney disease. Endocr Pract (2007) 0.75